| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PNAS..10813118D |
| P356 | DOI | 10.1073/PNAS.1104614108 |
| P932 | PMC publication ID | 3156183 |
| P698 | PubMed publication ID | 21778406 |
| P5875 | ResearchGate publication ID | 51510897 |
| P50 | author | David W. Borhani | Q42390809 |
| Ron Ofer Dror | Q59678272 | ||
| Huafeng Xu | Q61146872 | ||
| P2093 | author name string | David E Shaw | |
| Yibing Shan | |||
| Albert C Pan | |||
| Daniel H Arlow | |||
| Paul Maragakis | |||
| P2860 | cites work | High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 |
| Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
| Conserved Binding Mode of Human β 2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography | Q27663654 | ||
| All-atom empirical potential for molecular modeling and dynamics studies of proteins | Q27860468 | ||
| GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function | Q28254935 | ||
| A ligand channel through the G protein coupled receptor opsin | Q28474703 | ||
| The structure and function of G-protein-coupled receptors | Q29616792 | ||
| Mechanism of fast peptide recognition by SH3 domains | Q30157539 | ||
| Electrostatic funneling of substrate in mitochondrial inner membrane carriers | Q30482734 | ||
| Structure-based discovery of beta2-adrenergic receptor ligands | Q33426241 | ||
| A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor | Q33885350 | ||
| Drug-target residence time: critical information for lead optimization. | Q34054343 | ||
| 7 Isothermal Titration Calorimetry in Drug Discovery | Q34483315 | ||
| Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding | Q35076839 | ||
| Ligand binding: molecular mechanics calculation of the streptavidin-biotin rupture force | Q36793608 | ||
| Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
| NMR spectroscopy brings invisible protein states into focus | Q37617946 | ||
| Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes | Q39089506 | ||
| Fundamental difference between the molecular interactions of agonists and antagonists with the β-adrenergic receptor | Q39265422 | ||
| How does a drug molecule find its target binding site? | Q39280041 | ||
| Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor | Q39972557 | ||
| Ligand entry and exit pathways in the beta2-adrenergic receptor | Q42933080 | ||
| Negative cooperativity among beta-adrenergic receptors in frog erythrocyte membranes | Q44182279 | ||
| Measurement of the millisecond activation switch of G protein-coupled receptors in living cells | Q44479240 | ||
| Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol binding | Q44966034 | ||
| Observation of a dewetting transition in the collapse of the melittin tetramer | Q46681654 | ||
| Computer simulations of the diffusion of a substrate to an active site of an enzyme | Q52594370 | ||
| Time-resolved structural studies of protein reaction dynamics: a smorgasbord of X-ray approaches. | Q55651990 | ||
| Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
| Modification of the binding properties of muscarinic receptors by gallamine | Q71773661 | ||
| Adrenergic ligand liposolubility in membranes. Direct assessment in a beta-adrenergic binding system | Q72952843 | ||
| Ligand binding with stopped-flow rapid mixing | Q81820158 | ||
| Dewetting-controlled binding of ligands to hydrophobic pockets | Q84884849 | ||
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 13118-13123 | |
| P577 | publication date | 2011-07-21 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Pathway and mechanism of drug binding to G-protein-coupled receptors | |
| P478 | volume | 108 |
| Q39213631 | A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes |
| Q64251681 | A Metadynamics-Based Protocol for the Determination of GPCR-Ligand Binding Modes |
| Q42381285 | A Quantitative Model for cAMP Binding to the Binding Domain of MloK1. |
| Q48042725 | A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors |
| Q58465767 | A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors |
| Q38610941 | A cross docking pipeline for improving pose prediction and virtual screening performance. |
| Q38025530 | A crystal clear solution for determining G-protein-coupled receptor structures |
| Q28543750 | A dynamic view of molecular switch behavior at serotonin receptors: implications for functional selectivity |
| Q42380933 | A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4. |
| Q47935295 | A kinetic view of GPCR allostery and biased agonism |
| Q39103103 | A label-free optical biosensor with microfluidics identifies an intracellular signalling wave mediated through the β(2)-adrenergic receptor |
| Q90468092 | A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecule Yoda1 |
| Q47441641 | A monoclonal antibody raised against a thermo-stabilised β1-adrenoceptor interacts with extracellular loop 2 and acts as a negative allosteric modulator of a sub-set of β1-adrenoceptors expressed in stable cell lines. |
| Q50616685 | A pose prediction approach based on ligand 3D shape similarity |
| Q37325626 | A single glycine in extracellular loop 1 is the critical determinant for pharmacological specificity of dopamine D2 and D3 receptors. |
| Q39411714 | A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design |
| Q34402706 | ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader |
| Q36282684 | Accelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potential |
| Q33699049 | Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor |
| Q37281443 | Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor |
| Q57168288 | Acceleration of biomolecular kinetics in Gaussian accelerated molecular dynamics |
| Q59070946 | Activation of the A2A adenosine G-protein-coupled receptor by conformational selection |
| Q47979078 | Activation processes in ligand-activated G protein-coupled receptors: A case study of the adenosine A2A receptor |
| Q38698407 | Advances in free-energy-based simulations of protein folding and ligand binding. |
| Q35926130 | Agonist Dynamics and Conformational Selection during Microsecond Simulations of the A2A Adenosine Receptor |
| Q34244290 | Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism |
| Q51749525 | Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines |
| Q39643038 | Allosteric coupling from G protein to the agonist-binding pocket in GPCRs |
| Q28834286 | An Empirical Polarizable Force Field Based on the Classical Drude Oscillator Model: Development History and Recent Applications |
| Q91740794 | An Overview of Molecular Modeling for Drug Discovery with Specific Illustrative Examples of Applications |
| Q28834607 | Asynchronous Replica Exchange Software for Grid and Heterogeneous Computing |
| Q55093077 | Atomic resolution mechanism of ligand binding to a solvent inaccessible cavity in T4 lysozyme. |
| Q43569767 | Avidity and positive allosteric modulation/cooperativity act hand in hand to increase the residence time of bivalent receptor ligands |
| Q40028443 | Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor |
| Q30392142 | Beyond Membrane Protein Structure: Drug Discovery, Dynamics and Difficulties |
| Q38155468 | Beyond standard molecular dynamics: investigating the molecular mechanisms of G protein-coupled receptors with enhanced molecular dynamics methods. |
| Q38918905 | Binding Kinetics in Drug Discovery |
| Q51750607 | Binding kinetics of ZM241385 derivatives at the human adenosine A2A receptor |
| Q64073208 | Binding kinetics of ligands acting at GPCRs |
| Q28468325 | Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors |
| Q100946468 | Binding pathway determines norepinephrine selectivity for the human β1AR over β2AR |
| Q40390385 | Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter |
| Q55092101 | Binding, Thermodynamics, and Selectivity of a Non-peptide Antagonist to the Melanocortin-4 Receptor. |
| Q52331594 | Biomolecular conformational changes and ligand binding: from kinetics to thermodynamics |
| Q58719254 | Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview |
| Q36218659 | Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor? |
| Q36806838 | Capture and quality control mechanisms for adenosine-5'-triphosphate binding |
| Q38822818 | Cell membranes… and how long drugs may exert beneficial pharmacological activity in vivo |
| Q38077229 | Characterization of the dynamic events of GPCRs by automated computational simulations |
| Q38305637 | Coarse-grained molecular dynamics simulations of protein-ligand binding. |
| Q37697030 | Collective variable approaches for single molecule flexible fitting and enhanced sampling |
| Q38366350 | Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery |
| Q83224304 | Common activation mechanism of class A GPCRs |
| Q51466664 | Communication: Quantum polarized fluctuating charge model: a practical method to include ligand polarizability in biomolecular simulations |
| Q30521288 | Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity |
| Q34968064 | Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor |
| Q57975272 | Computational Approaches for Studying Drug Binding Kinetics |
| Q27311564 | Computational Study on the Different Ligands Induced Conformation Change of β2 Adrenergic Receptor-Gs Protein Complex |
| Q28537984 | Computational prediction of alanine scanning and ligand binding energetics in G-protein coupled receptors |
| Q46204855 | Conformational Ensembles in GPCR Activation |
| Q91717203 | Conformational pathway provides unique sensitivity to a synaptic mGluR |
| Q89518414 | Conformational plasticity of ligand-bound and ternary GPCR complexes studied by 19F NMR of the β1-adrenergic receptor |
| Q46377411 | Contributions of water transfer energy to protein-ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors |
| Q60910349 | Designing Hybrids Targeting the Cholinergic System by Modulating the Muscarinic and Nicotinic Receptors: A Concept to Treat Alzheimer's Disease |
| Q91754192 | Determinants of Orexin Receptor Binding and Activation-A Molecular Dynamics Study |
| Q48178014 | Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents |
| Q38973719 | Discrimination between olfactory receptor agonists and non-agonists |
| Q47714485 | Distinct in vivo target occupancy by bivalent- and induced-fit-like binding drugs |
| Q64272590 | Diverse GPCRs exhibit conserved water networks for stabilization and activation |
| Q64969552 | Does the lipid bilayer orchestrate access and binding of ligands to transmembrane orthosteric/allosteric sites of GPCRs? |
| Q49448169 | Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs |
| Q92122756 | Drug-Target Association Kinetics in Drug Discovery |
| Q47374327 | Dynamic Docking: A Paradigm Shift in Computational Drug Discovery |
| Q86706640 | Dynamics and structural determinants of ligand recognition of the 5-HT6 receptor |
| Q41677949 | Effect of material flexibility on the thermodynamics and kinetics of hydrophobically induced evaporation of water |
| Q27301215 | Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide |
| Q37257220 | Efficient determination of protein-protein standard binding free energies from first principles |
| Q46956792 | Efficient optimization of van der Waals parameters from bulk properties |
| Q38200338 | Employing novel animal models in the design of clinically efficacious GPCR ligands |
| Q92882026 | Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape |
| Q27009220 | Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations |
| Q47110210 | Energetics of Glutamate Binding to an Ionotropic Glutamate Receptor. |
| Q92490700 | Enhancing Drug Residence Time by Shielding of Intra-Protein Hydrogen Bonds: A Case Study on CCR2 Antagonists |
| Q57044175 | Entry from the Lipid Bilayer: A Possible Pathway for Inhibition of a Peptide G Protein-Coupled Receptor by a Lipophilic Small Molecule |
| Q91163608 | Estimation of Protein-Ligand Unbinding Kinetics Using Non-Equilibrium Targeted Molecular Dynamics Simulations |
| Q38737287 | Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies |
| Q39257749 | Evaluation of protein-ligand affinity prediction using steered molecular dynamics simulations |
| Q36342813 | Exploration of gated ligand binding recognizes an allosteric site for blocking FABP4-protein interaction |
| Q48296107 | Exploration of the antagonist CP-376395 escape pathway for the corticotropin-releasing factor receptor 1 by random acceleration molecular dynamics simulations. |
| Q53076714 | Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. |
| Q57496184 | Exploring a new ligand binding site of G protein-coupled receptors |
| Q30394046 | Exploring the mechanism of F282L mutation-caused constitutive activity of GPCR by a computational study |
| Q51451305 | Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy. |
| Q47567885 | Finding the needle in the haystack: towards solving the protein-folding problem computationally. |
| Q64951410 | Fingerprint-Based Machine Learning Approach to Identify Potent and Selective 5-HT2BR Ligands. |
| Q36692853 | Free energy landscape for the binding process of Huperzine A to acetylcholinesterase |
| Q26750941 | From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins |
| Q51069247 | From molecular dynamics to Brownian dynamics |
| Q55511977 | Full rescue of an inactive olfactory receptor mutant by elimination of an allosteric ligand-gating site. |
| Q30459151 | Function and dynamics of macromolecular complexes explored by integrative structural and computational biology |
| Q30539051 | Funnel metadynamics as accurate binding free-energy method |
| Q33639685 | G protein-coupled receptors in cardiac biology: old and new receptors |
| Q39419666 | G-Protein coupled receptors: answers from simulations |
| Q38300811 | G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent. |
| Q38848557 | G-protein coupled receptors: advances in simulation and drug discovery |
| Q38067899 | GPCR activation: a mutagenic spotlight on crystal structures |
| Q38830600 | GPCRs through the keyhole: the role of protein flexibility in ligand binding to β-adrenoceptors. |
| Q47348724 | GPCRs: What Can We Learn from Molecular Dynamics Simulations? |
| Q48050759 | Gaussian Accelerated Molecular Dynamics in NAMD. |
| Q55481649 | Gaussian Accelerated Molecular Dynamics: Theory, Implementation, and Applications. |
| Q58080237 | Gaussian accelerated molecular dynamics for elucidation of drug pathways |
| Q37379758 | Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor |
| Q30371326 | Hierarchical domain-motion analysis of conformational changes in sarcoplasmic reticulum Ca²⁺-ATPase. |
| Q34457250 | High-Throughput parallel blind Virtual Screening using BINDSURF. |
| Q27675402 | High-resolution crystal structure of human protease-activated receptor 1 |
| Q41870119 | Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action |
| Q43757698 | How Ligands Illuminate GPCR Molecular Pharmacology |
| Q44340976 | How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways |
| Q37103848 | How hydrophobic drying forces impact the kinetics of molecular recognition |
| Q30413750 | Identification of Domains in Protein Structures from the Analysis of Intramolecular Interactions |
| Q48259913 | Identifying human diamine sensors for death related putrescine and cadaverine molecules |
| Q38023797 | Impact of helix irregularities on sequence alignment and homology modeling of G protein-coupled receptors |
| Q47225761 | Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A2A ligand binding kinetics |
| Q49234399 | Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor |
| Q37280290 | Improved estimation of protein-ligand binding free energy by using the ligand-entropy and mobility of water molecules |
| Q47094111 | Improving virtual screening of G protein-coupled receptors via ligand-directed modeling. |
| Q50675544 | In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation. |
| Q39165104 | Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures. |
| Q31118641 | Integrating structural and mutagenesis data to elucidate GPCR ligand binding. |
| Q58769381 | Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes |
| Q47132843 | Investigating Small-Molecule Ligand Binding to G Protein-Coupled Receptors with Biased or Unbiased Molecular Dynamics Simulations |
| Q56989238 | Investigating allosteric effects on the functional dynamics of β2-adrenergic ternary complexes with enhanced-sampling simulations |
| Q45376369 | Is there room for non-dopaminergic treatment in Parkinson disease? |
| Q38810731 | Kinetic Aspects of the Interaction between Ligand and G Protein-Coupled Receptor: The Case of the Adenosine Receptors |
| Q51604998 | Let's get honest about sampling. |
| Q49374902 | Ligand Binding Pathways and Conformational Transitions of the HIV Protease |
| Q57275094 | Ligand induced change of β2adrenergic receptor from active to inactive conformation and its implication for the closed/open state of the water channel: insight from molecular dynamics simulation, free energy calculation and Markov state model analys |
| Q34754684 | Ligand migration through hemeprotein cavities: insights from laser flash photolysis and molecular dynamics simulations. |
| Q42380834 | Ligand modulation of sidechain dynamics in a wild-type human GPCR. |
| Q57794695 | Ligand selection from the analysis of protein conformational substates: new leads targeting the N-terminal domain of Hsp90 |
| Q38031893 | Ligand-receptor interaction platforms and their applications for drug discovery. |
| Q41283780 | Limiting assumptions in molecular modeling: electrostatics |
| Q57133316 | Link between a high for drug binding and a fast clinical action: to be or not to be? |
| Q55428978 | LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner. |
| Q35887173 | Locating binding poses in protein-ligand systems using reconnaissance metadynamics |
| Q64911982 | Machine Learning Analysis of τRAMD Trajectories to Decipher Molecular Determinants of Drug-Target Residence Times. |
| Q64285708 | Machine Learning of Coarse-Grained Molecular Dynamics Force Fields |
| Q45327668 | Mapping the Functional Binding Sites of Cholesterol in β2-Adrenergic Receptor by Long-Time Molecular Dynamics Simulations |
| Q33879450 | Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease. |
| Q53839652 | Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor |
| Q30443341 | Modeling and simulation of ion channels |
| Q36175542 | Modeling molecular kinetics with tICA and the kernel trick |
| Q47348698 | Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time |
| Q52884916 | Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor |
| Q48020118 | Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction |
| Q91588369 | Molecular Dynamics Simulation for All |
| Q51603766 | Molecular Dynamics Simulations of G Protein-Coupled Receptors |
| Q90559357 | Molecular Mechanism of S1P Binding and Activation of the S1P1 Receptor |
| Q39007384 | Molecular Modelling Approaches for the Analysis of Histamine Receptors and Their Interaction with Ligands |
| Q38066121 | Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors |
| Q83345175 | Molecular dynamics simulations for glutamate-binding and cleft-closing processes of the ligand-binding domain of GluR2 |
| Q28542663 | Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor |
| Q52597866 | Molecular mechanism of activation of human musk receptors OR5AN1 and OR1A1 by (R)-muscone and diverse other musk-smelling compounds. |
| Q34327700 | Molecular signatures of G-protein-coupled receptors |
| Q84381547 | Molecular‐Dynamics Simulation of Dioxygen Egress from 12/15‐LipoxygenaseArachidonic Acid Complex |
| Q37183610 | Multiensemble Markov models of molecular thermodynamics and kinetics. |
| Q35822656 | Multiscale Estimation of Binding Kinetics Using Brownian Dynamics, Molecular Dynamics and Milestoning |
| Q47911476 | Neurotransmitter Funneling Optimizes Glutamate Receptor Kinetics. |
| Q38933295 | New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova |
| Q84815383 | On CO Egress from, and Re‐Uptake by, the Enzyme MauG, as a Mimic of the Acquisition of Oxidizing Agents by the pre‐MADH_MauG System. A Molecular Mechanics Approach |
| Q61817296 | On identifying collective displacements in apo-proteins that reveal eventual binding pathways |
| Q38545579 | On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action |
| Q36518432 | On the Importance of Hydrodynamic Interactions in Lipid Membrane Formation |
| Q45265253 | On the Pathways for CO Egress from Carboxy Human Cytoglobin. A Molecular‐Dynamics Investigation |
| Q38710840 | On the different experimental manifestations of two-state 'induced-fit' binding of drugs to their cellular targets |
| Q24321210 | Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization |
| Q35578839 | Peptide Binding to a PDZ Domain by Electrostatic Steering via Nonnative Salt Bridges |
| Q57292518 | Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations |
| Q47625069 | Prediction of binding poses to FXR using multi-targeted docking combined with molecular dynamics and enhanced sampling. |
| Q34456030 | Probability fluxes and transition paths in a Markovian model describing complex subunit cooperativity in HCN2 channels |
| Q35643579 | Probing binding pocket of serotonin transporter by single molecular force spectroscopy on living cells. |
| Q38542935 | Progress toward rationally designed small-molecule peptide and peptidomimetic CXCR4 antagonists |
| Q21090966 | Protein 3D structure computed from evolutionary sequence variation |
| Q40776037 | Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models |
| Q34093006 | Protein dynamics via computational microscope |
| Q56961708 | Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling |
| Q97692526 | Protein-ligand binding with the coarse-grained Martini model |
| Q57160189 | Quantitative Ranking of Ligand Binding Kinetics with a Multiscale Milestoning Simulation Approach |
| Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
| Q93017246 | Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery |
| Q57175255 | Recent Trends and Applications of Molecular Modeling in GPCR⁻Ligand Recognition and Structure-Based Drug Design |
| Q42277415 | Retinal Flips the Script |
| Q26747130 | Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations |
| Q34680443 | Role of Desolvation in Thermodynamics and Kinetics of Ligand Binding to a Kinase |
| Q57471905 | Role of Extracellular Loops and Membrane Lipids for Ligand Recognition in the Neuronal Adenosine Receptor Type 2A: An Enhanced Sampling Simulation Study |
| Q48247516 | SEEKR: Simulation Enabled Estimation of Kinetic Rates, A Computational Tool to Estimate Molecular Kinetics and Its Application to Trypsin-Benzamidine Binding. |
| Q90108447 | STACKED - Solvation Theory of Aromatic Complexes as Key for Estimating Drug Binding |
| Q27346663 | Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations |
| Q47952563 | Simulation of Ligand Binding to Membrane Proteins. |
| Q39547080 | Simulation of the mutation F76del on the von Hippel–Lindau tumor suppressor protein: Mechanism of the disease and implications for drug development |
| Q41817389 | Single-molecule analysis of the rotation of F₁-ATPase under high hydrostatic pressure |
| Q60960514 | Solvents to Fragments to Drugs: MD Applications in Drug Design |
| Q91235937 | Spontaneous Ligand Access Events to Membrane-Bound Cytochrome P450 2D6 Sampled at Atomic Resolution |
| Q30540733 | Standard binding free energies from computer simulations: What is the best strategy? |
| Q37277307 | Statistical estimation of the protein-ligand binding free energy based on direct protein-ligand interaction obtained by molecular dynamics simulation |
| Q59340309 | Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A Receptor |
| Q42694413 | Structural Basis for G Protein-Coupled Receptor Activation |
| Q90332751 | Structural Features and Ligand Selectivity for 10 Intermediates in the Activation Process of β2-Adrenergic Receptor |
| Q97644040 | Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor |
| Q34651994 | Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study |
| Q50470980 | Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. |
| Q36796209 | Structural insights and functional implications of inter-individual variability in β2-adrenergic receptor |
| Q57452393 | Structural insights into binding specificity, efficacy and bias of a βAR partial agonist |
| Q28088311 | Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs |
| Q53826190 | Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions. |
| Q93017485 | Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor |
| Q27677433 | Structure and dynamics of the M3 muscarinic acetylcholine receptor |
| Q30576993 | Structure-function of the G protein-coupled receptor superfamily |
| Q62649644 | Structure-kinetic relationships that control the residence time of drug-target complexes: insights from molecular structure and dynamics |
| Q47250664 | Systematic exploration of multiple drug binding sites |
| Q38671149 | The Arg-Phe-amide peptide 26RFa/QRFP and its Receptor. IUPHAR Review |
| Q34489039 | The Dynamic Process of Drug-GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics |
| Q38949395 | The Role of Target Binding Kinetics in Drug Discovery |
| Q34297570 | The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling |
| Q36651876 | The dynamic process of β(2)-adrenergic receptor activation |
| Q34241696 | The future of molecular dynamics simulations in drug discovery |
| Q30618624 | The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning. |
| Q27334167 | The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor |
| Q38237899 | The receptor concept in 3D: from hypothesis and metaphor to GPCR-ligand structures |
| Q37149545 | The role of ligands on the equilibria between functional states of a G protein-coupled receptor |
| Q30408394 | The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers |
| Q59287278 | The size matters? A computational tool to design bivalent ligands |
| Q50080361 | The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptor |
| Q24630589 | Three-dimensional structures of membrane proteins from genomic sequencing |
| Q46013288 | Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery |
| Q33888491 | Tyrosine 308 is necessary for ligand-directed Gs protein-biased signaling of β2-adrenoceptor |
| Q48178136 | Understanding How H‐NOX (Heme Nitric Oxide/Oxygen) Domain Works Needs First Clarifying How Diatomic Gases Are Relocated Inside This Sensing Protein. A Molecular‐Mechanics Approach |
| Q92268977 | Understanding Ligand Binding Selectivity in a Prototypical GPCR Family |
| Q64068088 | Understanding Ligand Binding to G-Protein Coupled Receptors Using Multiscale Simulations |
| Q33796500 | Understanding ligand-receptor non-covalent binding kinetics using molecular modeling. |
| Q53510547 | Understanding selective molecular recognition in integrated carbon nanotube-polymer sensors by simulating physical analyte binding on carbon nanotube-polymer scaffolds |
| Q92409897 | Utilization of Biased G Protein-Coupled ReceptorSignaling towards Development of Safer andPersonalized Therapeutics |
| Q91593329 | Variational implicit-solvent predictions of the dry-wet transition pathways for ligand-receptor binding and unbinding kinetics |
| Q26826746 | Visualizing functional motions of membrane transporters with molecular dynamics simulations |
| Q34785448 | What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands? |
Search more.